TG Therapeutics (TGTX) PT Lowered to $20 at Ladenburg Thalmann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies
April 19, 2022 8:36 AM EDTJefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "During Monday morning's press conference TG announced it's pausing its oncology programs. The decision was made based on updated... More
